Live Breaking News & Updates on Agena Bioscience Mass
Stay updated with breaking news from Agena bioscience mass. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Share: Kaiserslautern, Germany, February 22, 2021 – SEQ-IT, a leading molecular services provider, today announced they completed a novel mass spectrometry based rapid test for the detection of 20 of the most relevant SARS-CoV-2 mutations including the UK (B.1.1.7), South African and Brazilian variants. The test panel was developed using Agena Bioscience s MassARRAY® System, a well-established tool used by clinical laboratories worldwide to deliver affordable, highly accurate genomic testing. SEQ-IT has been heavily involved in the COVID-19 pandemic response since its beginning. We strive to consistently adapt and improve our testing services to respond to the dynamically changing needs in this crisis. The MassARRAY® System puts us in the position to quickly and reliably test samples for the most relevant Corona variants, said Dr. Bernhard Thiele, CEO of SEQ-IT. ....